Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
DR. BERNARD PEENE, Endocrinologie from Herselt, company number BE0682926718, closed financial year 2025 with a result of € 159,235 after tax. For that financial year DR. BERNARD PEENE, Endocrinologie recorded a gross margin of € 240,221 and equity of € 27,999. Compared with financial year 2024, the result moved from € 128,655 to € 159,235. Profitable, and profit is growing. The buffer shrank hard: equity is 81 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ 27,999
▼ 81% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 159,235
▲ 24% vs 2024
Profit after tax over the fiscal year.
€ 166,256
Cash and bank balances on the last day of the fiscal year.
€ 279,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 56,355
▲ 161% vs 2024
Of which on lease € 52,708.
Debts at end 2025
€ 212,418
▲ 9% vs 2024
€ 32,100 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 513
▼ 70% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 60
▼ € 18,563 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 172,022 | € 205,012 | € 193,671 | € 240,221 | ▲ 24% |
| Profit after taxes | € 119,626 | € 130,047 | € 128,655 | € 159,235 | ▲ 24% |
| Equity | € 139,063 | € 149,110 | € 147,764 | € 27,999 | ▼ 81% |
| Total debts | € 180,198 | € 250,727 | € 321,248 | € 482,277 | ▲ 50% |
| Cash | € 106,395 | € 99,054 | € 166,667 | € 166,256 | |
| Land & buildings | - | € 95,650 | € 93,275 | € 90,899 | ▼ 3% |
| Retained profit | € 120,463 | € 130,510 | € 129,164 | € 9,399 | ▼ 93% |
| Dividend | € 112,000 | € 120,000 | € 130,000 | € 279,000 | ▲ 115% |
| Bank debt | € 167,527 | € 220,434 | € 194,728 | € 212,418 | ▲ 9% |
| Balance sheet total | € 319,261 | € 399,836 | € 469,013 | € 510,276 | ▲ 9% |
Key figures of DR. BERNARD PEENE, Endocrinologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DR. BERNARD PEENE, Endocrinologie?
What happened at DR. BERNARD PEENE, Endocrinologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 159,235 (▲ 24% vs 2024). Source: NBB ↗
- New establishment in Herselt. KBO
- Start of the company according to the CBE. KBO
- Bernard PEENE became a director. NBB
In short
From € 119,626 profit in 2022 to € 159,235 profit in 2025.
Paid € 160,789 in corporate taxes since 2022.
Best year ever: 2025, with € 159,235 profit.
Paid out € 641,000 in dividends to the owners in total.
A new publication or filing at DR. BERNARD PEENE, Endocrinologie? We notify you, reason included.
Follow DR. BERNARD PEENE, EndocrinologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DR. BERNARD PEENE, Endocrinologie is Bernard PEENE.
Directors
According to the 2025 annual accounts
Bernard PEENE
Director
since 2017
Establishments
Establishment units
Physical locations of this company
Oude Baan 65
2230 Herselt
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0682.926.718
- VAT number
- BE 0682.926.718
- Registered office
- Oude Baan 65, 2230 Herselt
- Names & denominations
- DR. BERNARD PEENE, Endocrinologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 October 2017
- Peppol
- Active · Active since 29 Jul 2024
- Activities · NACE
Activiteiten van medisch specialisten
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Diverse administratieve activiteiten ten behoeve van kantoren